Abstract
Malaria is a global disease of importance, especially in the sub-Saharan African region, where malaria accounts for great losses economically and to life. Fight to eliminate this disease has resulted in reduced disease burden in many places where the diseases is endemic. Elimination strategies in most places is focus on the use of treated nets and drug application. Exposure of malaria parasites to anti-malaria drugs have led to the evolution of drug resistance in both parasites and host. Development of drug resistance vary but, studies on adaptive drug resistance has implications and consequences. Our knowledge of this consequences are limited but important for the pursuit of an uninterrupted malaria elimination agenda. This chapter draws our attention to this risks and recommends interventions.
Reference56 articles.
1. World Health Organization 2015. Global Malaria Programme. Eliminating malaria. Geneva: World Health Organization. World Health. 2015;243
2. Talapko, J., Škrlec, I., Alebić, T., Jukić, M. and Včev, A. 2019. Malaria: The past and the present. Microorganisms, 7(6), 179. MDPI AG. http://dx.doi.org/10.3390/microorganisms7060179
3. White, M.T., Karl, S., Koepfli, C. Longley, R.J., Hofmann, N.E., Wampflier, R., Felger, I., Smith, T., Nguitragool, W., Sattabongkot, J., Robinson, L. Ghani, A. and Mueller I. 2018. Plasmodium vivax and plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses. Malar J 17 (170). https://doi.org/10.1186/s12936-018-2318-1
4. de Jong, S.E., van Unen, V., Manurung, M.D. et al. Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity. Nat Immunol 22, 654-665 (2021). https://doi.org/10.1038/s41590-021-00911-7
5. World Health Organization 2020. World Malaria Report. https://www.who.int/malaria/publications/world- repot-malaria-report-2019/en/. Accessed 10 September, 2020